UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 395

Sortiert nach

Uso juicioso de los smartphones en las consultas de atención primaria

Atención primaria, 2024-09, Vol.56 (9), p.102975, Article 102975

2024

Link zum Volltext

Verfügbarkeit prüfen

Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort

Blood cancer journal (New York), 2023-05, Vol.13 (1), p.69-69, Article 69

2023

Link zum Volltext

Verfügbarkeit prüfen

LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors

Frontiers in immunology, 2023-01, Vol.14, p.1066393-1066393

2023

Link zum Volltext

Verfügbarkeit prüfen

DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features

Epigenetics, 2018-01, Vol.13 (1), p.8-18

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes after CPX‐351 in patients with high‐risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry

Cancer medicine (Malden, MA), 2023-07, Vol.12 (14), p.14892-14901

2023

Link zum Volltext

Verfügbarkeit prüfen

Low doses of gemtuzumab ozogamicin in adults diagnosed with acute myeloid leukaemia

Medicina clinica, 2021-10, Vol.157 (7), p.325

2021

Link zum Volltext

Verfügbarkeit prüfen

Uso juicioso de los smartphones en las consultas de atención primaria

Atención primaria, 2024-05, Vol.56 (9)

2024

Link zum Volltext

Verfügbarkeit prüfen

Judicious use of smartphones in primary care consultations

Atención primaria, 2024-05, Vol.56 (9), p.102975-102975

2024

Link zum Volltext

Verfügbarkeit prüfen

1341 - ROL DE LA SARCOPENIA Y LA RESISTENCIA A LA INSULINA EN LA RELACIÓN ENTRE FRAGILIDAD Y SOLEDAD NO DESEADA

Revista clínica espanõla, 2023-11, Vol.223, p.S490-S491

2023

Link zum Volltext

Verfügbarkeit prüfen

Venetoclax Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia

Blood, 2021-11, Vol.138 (Supplement 1), p.4421-4421

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-Life Experience of Use of Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia. a Single Center Experience

Blood, 2022-11, Vol.140 (Supplement 1), p.9021-9022

2022

Link zum Volltext

Verfügbarkeit prüfen

Iadademstat Combination with Azacitidine Is a Safe and Effective Treatment in First Line Acute Myeloid Leukemia. Final Results of the Alice Trial

Blood, 2022-11, Vol.140 (Supplement 1), p.1711-1713

2022

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

Scientific reports, 2024-03, Vol.14 (1), p.7400-7400, Article 7400

2024

Link zum Volltext

Verfügbarkeit prüfen

Iadademstat in Combination with Azacitidine Generates Robust and Long Lasting Responses in AML Patients (ALICE Trial)

Blood, 2021-11, Vol.138 (Supplement 1), p.3376-3376

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of Deferasirox Combined with Erythropoietin Versus Erythropoietin Alone on Erythroid Response in Patients with Low- and Int-1-Risk Myelodysplastic Syndromes: Results of the Phase II Kallisto Trial

Blood, 2017-12, Vol.130, p.2984-2984

2017

Link zum Volltext

Verfügbarkeit prüfen

Mutational profile and relative telomere length in Chronic Myelomonocytic Leukemia subgroups according to the 2016 World Health Organization classification

Leukemia research, 2021-12, Vol.111, p.106726-106726, Article 106726

2021

Link zum Volltext

Verfügbarkeit prüfen

RAS Mutations in Adult Acute Myeloid Leukemia (AML). Frequency, Mutational Spectrum, and Identification of a Comutation Bias for KRAS K117 ( TET2 / ASXL1 )

Blood, 2022-11, Vol.140 (Supplement 1), p.11821-11823

2022

Link zum Volltext

Verfügbarkeit prüfen

Prognostic heterogeneity of adult B‐cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3‐PBX1 treated with measurable residual disease‐oriented protocols

British journal of haematology, 2022-02, Vol.196 (3), p.670-675

2022

Link zum Volltext

Verfügbarkeit prüfen

Genomic Data Improves Prognostic Stratification in Adult T-Cell Acute Lymphoblastic Leukemia Patients Enrolled in Measurable Residual Disease-Oriented Trials

Blood, 2021-11, Vol.138 (Supplement 1), p.3486-3486

2021

Link zum Volltext

Verfügbarkeit prüfen

Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials

Haematologica (Roma), 2023-04, Vol.108 (4), p.969

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 395

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(346)
Mit Volltextzugriff
(360)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Uso juicioso de los smartphones en las consultas de atención primaria

Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort

LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors

DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features

Clinical outcomes after CPX‐351 in patients with high‐risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry

Impact of Center‐related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric‐inspired Protocols

Low doses of gemtuzumab ozogamicin in adults diagnosed with acute myeloid leukaemia

Uso juicioso de los smartphones en las consultas de atención primaria

Judicious use of smartphones in primary care consultations

1341 - ROL DE LA SARCOPENIA Y LA RESISTENCIA A LA INSULINA EN LA RELACIÓN ENTRE FRAGILIDAD Y SOLEDAD NO DESEADA

Venetoclax Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia

Real-Life Experience of Use of Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia. a Single Center Experience

Iadademstat Combination with Azacitidine Is a Safe and Effective Treatment in First Line Acute Myeloid Leukemia. Final Results of the Alice Trial

Author Correction: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

Iadademstat in Combination with Azacitidine Generates Robust and Long Lasting Responses in AML Patients (ALICE Trial)

Effect of Deferasirox Combined with Erythropoietin Versus Erythropoietin Alone on Erythroid Response in Patients with Low- and Int-1-Risk Myelodysplastic Syndromes: Results of the Phase II Kallisto Trial

Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease

Mutational profile and relative telomere length in Chronic Myelomonocytic Leukemia subgroups according to the 2016 World Health Organization classification

RAS Mutations in Adult Acute Myeloid Leukemia (AML). Frequency, Mutational Spectrum, and Identification of a Comutation Bias for KRASK117 (TET2/ASXL1)

Long-Term Evolution of Somatic Mutations in Patients with Del(5q) MDS Early Treated with Lenalidomide in the Sintra-Rev Clinical Trial: Safe and Effecitive Approach?

RAS Mutations in Adult Acute Myeloid Leukemia (AML). Frequency, Mutational Spectrum, and Identification of a Comutation Bias for KRAS K117 ( TET2 / ASXL1 )

Prognostic heterogeneity of adult B‐cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3‐PBX1 treated with measurable residual disease‐oriented protocols

Genomic Data Improves Prognostic Stratification in Adult T-Cell Acute Lymphoblastic Leukemia Patients Enrolled in Measurable Residual Disease-Oriented Trials

Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice

Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials

Suchergebnisse filtern